Welcome to the e-CCO Library!

P743 Time trends of Crohn’s disease in Catalonia from 2011 to 2017. Increasing use of biologics correlates with a reduced need for surgery. A population-based study in Catalonia
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Brunet1, L. Melcarne1, E. Vela2, M. Clèries2, C. Pontes3,4, P. García-Iglesias1,5, M. Gallach1, L. Hernández1, A. Soria1, V. Jordi1, P. Pedregal1, G. Grau1, B. Garcia-Sagué1, L.E. Frisancho1, A. Villòria1,5,6, M. Vergara1,5,6, X. Calvet1,5,6

Created: Thursday, 30 January 2020, 10:12 AM
P743: Bone mineral disease is insufficiently evaluated in patients with inflammatory bowel disease at risk of metabolic bone disease: results from a Danish population-based inception cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Lo*1, I. Vind1, M. K. Vester-Andersen1,2, J. P. Holm3, F. Bendtsen1, J. Burisch1

Created: Friday, 22 February 2019, 9:41 AM
P743: Ustekinumab use in Crohn´s Disease: Does short-term effectiveness correlate to induction regimen?
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Gutiérrez1,2*, L. Sempere1, R. Laveda3, M.F. García4

Created: Thursday, 21 February 2019, 9:14 AM
P743: What information is available on the internet and social media for faecal microbiota transplantation?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Segal J.1, Abbasi F.*2, Kanagasundram C.3, Hart A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Chaparro1, M. Barreiro-de Acosta2, J.M. Benítez3, J.L. Cabriada4, M.J. Casanova1, D. Ceballos5, M. Esteve6, H. Fernández7, D. Ginard8, F. Gomollón9, R. Lorente10, P. Nos11, S. Riestra12, M. Rivero13, P. Robledo14, C. Rodríguez15, B. Sicilia16, E. Torrella17, A. Garre1, F. Rodríguez-Artalejo18, E. García-Esquinas18, J.P. Gisbert1, on behalf of the EpidemIBD group of GETECCU

Created: Thursday, 30 January 2020, 10:12 AM
P744: A significant decline in surgical resections during childhood with increased prevalence of anti-TNF therapy in patients with paediatric inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. J. Ashton*1,2, F. Borca3, E. Mossotto2,3, T. Coelho1, A. Batra1, N. Afzal1, H. Phan3, M. Stanton1, S. Ennis2, R. M. Beattie1

Created: Friday, 22 February 2019, 9:41 AM
P744: Risk factors for faecal incontinence in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vollebregt P.1, Visscher A.1, van Bodegraven A.*1,2, Felt-Bersma R.1

Created: Wednesday, 20 February 2019, 10:36 AM
P744: Safety of live vaccines in children exposed to biological agents for inflammatory bowel disease (IBD) in utero or during breastfeeding
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chaparro, M.(1)*;García Donday, M.(1);Rubio, S.(2);Calviño Suarez, C.(3); Nuñez Ortiz, A.(4);Figueira, M.(5);Marín Pedrosa, S.(6);Rivero, M.(7); Fernández-Clotet, A.(8);Madero, L.(9);Diz-Lois Palomares, M.T.(10);Pérez-Martínez, I.(11);Ruiz-Cerulla, A.(12);Arroyo, M.(13);Piqueras, M.(14); Suarez Ferrer, C.(15);Aguas, M.(16);Calvo Moya, M.(17);Guerra, I.(18); López Serrano, P.(19);Vázquez Morón, J.M.(20);Arias García, L.(21);Casanova, M.J.(1);Huguet, J.M.(22);Valldosera Gomis, G.(23);Zúñiga de Mora-Figueroa, B.(24);Armesto, R.(25);Martínez Montiel, P.(26);Rodríguez-Lago, I.(27);Sendra Rumbeu, P.(28);Camargo Camero, R.(29);Hervías Cruz, D.(30);Molina Arriero, G.(31);Barreiro-de Acosta, M.(3);Acosta, D.(1);Brenes, Y.(1);Hermida, S.(1);Parra, P.(1);Garre, A.(1);Gisbert, J.P.(1);
Created: Friday, 14 July 2023, 11:12 AM
P744: Therapeutic gain of continued, long-term infliximab therapy in Crohn’s disease patients with response but non-remission after one year of infliximab therapy
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Buhl*, M.K. Borghede, J. Brynskov, C. Steenholdt, M. Rasmussen, M.A. Ainsworth

Created: Thursday, 21 February 2019, 9:14 AM
P745 Perianal disease in Crohn’s disease is associated with higher rate of hospitalisation and mortality despite a higher utilisation of biologics: Report from the epiIIRN cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. ATIA1, N. Asayag1, G. Focht1, A. Cahan2, I. Dotan3, R. Balicer4, M. Gavish5, B. Feldman4, I. Brufman4, Z. Haklai6, D. Turner1, Israeli IBD Research Nucleus (IIRN)

Created: Thursday, 30 January 2020, 10:12 AM
P745: Impact of migration on IBD incidence in 8 European populations: results from Epicom 2010 inception cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Misra R.*1, Burisch J.2, Shaji S.3, Salupere R.4, Ellul P.5, Ramirez V.6, D'Incà R.7, Munkholm P.2, Arebi N.8

Created: Wednesday, 20 February 2019, 10:36 AM
P745: Incidence of indeterminate colitis in the EPIMAD registry decreases over the period 1988–2014
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Mayer*1, H. Sarter2,3, M. Fumery2,4, G. Savoye5, A. Leroyer3, L. Dauchet3, C. Gower-Rousseau2,3, B. Pariente1

Created: Friday, 22 February 2019, 9:41 AM
P745: Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gros, B.(1,2)*;Plevris, N.(1);Constantine-Cooke, N.(3,4);Lyons, M.(1);O'Hare, C.(1,5);Noble, C.(1);Arnott, I.D.(1);Jones, G.R.(1,6);Lees, C.W.(1,4);Derikx, L.A.A.P.(1,7,8);
Created: Friday, 14 July 2023, 11:12 AM
P745: Switching between anti-TNF originator and biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.P. Gisbert1,2,3,4*, M. Chaparro1,2,3,4

Created: Thursday, 21 February 2019, 9:14 AM
P746 Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Masnou1, M. Mañosa2, L. Menchén3, F. Mesonero4, L. Bujanda5, J. Castro6, I. Gonzalez-Partida7, R. De Francisco8, F.J. García-Alonso9, M.J. García10, C. González-Muñoza11, J.M. Huguet12, M. Iborra13, N. Cano-Sanz14, E. Domènech Moral2, Eneida-GETECCU Registry

Created: Thursday, 30 January 2020, 10:12 AM
P746: Anthropometric measures in adolescents with inflammatory bowel disease: A population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Ghersin1*, L.H. Katz2, S. Daher3, R. Shamir4, A. Assa4

Created: Thursday, 21 February 2019, 9:14 AM
P746: Clinical characteristic of Crohn's disease patients in Polish population
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lodyga M.*1, Eder P.2, Gawron-Kiszka M.3, Hartleb M.3, Kierkus J.4, Klopocka M.5, Kukulska M.6, Linke K.7, Malecka-Panas E.8, Poniewierka E.6, Smola I.6, Rawa T.9, Regula J.9, Rydzewska G.1,10

Created: Wednesday, 20 February 2019, 10:36 AM
P746: Identification of Altered Microbial Genera at Baseline in Adalimumab Clinical Remitters and an Absence of Change in Total Microbial Composition Post Induction Treatment in the SERENE UC Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Morsy, Y.(1);Pivorunas, V.(2);Leitner, C.(3);Birchler, T.(4);Guay, H.(2);Scharl, M.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P746: Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Dignass*1, J. Waller2, J. C. Cappelleri3, L. Salese4, A. Kisser5, L. Dietz5, M. DiBonaventura6, R. Wood2, D. Bargo6

Created: Friday, 22 February 2019, 9:41 AM